StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
444
This month
16
This week
5
This year
16
Yesterday
3
Publishing Date
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 07 - 30
3
2021 - 07 - 27
2
2021 - 07 - 23
2
2021 - 07 - 16
2
2021 - 07 - 12
2
2021 - 07 - 09
3
2021 - 07 - 08
2
2021 - 07 - 01
2
2021 - 06 - 29
2
2021 - 06 - 25
3
2021 - 06 - 24
2
2021 - 06 - 17
3
2021 - 06 - 11
2
2021 - 06 - 10
5
2021 - 06 - 09
2
2021 - 06 - 04
3
2021 - 06 - 02
2
2021 - 05 - 25
2
2021 - 05 - 24
3
2021 - 05 - 21
2
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 14
3
2021 - 04 - 13
3
2021 - 04 - 12
2
2021 - 04 - 07
3
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 16
2
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Sector
Commercial services
1
Communications
1
Consumer non-durables
1
Consumer services
1
Distribution services
1
Electronic technology
2
Energy minerals
3
Finance
3
Finance and insurance
1
Health services
5
Health technology
443
Information
1
Manufacturing
42
N/a
6
Process industries
7
Producer manufacturing
1
Professional, scientific, and technical services
3
Retail trade
3
Technology services
2
Tags
Active
5
Alliances
12
Antibody
11
Antiviral
5
Application
16
Approval
40
Biotech
7
Biotech-bay
9
Biotechnology
5
Cancer
79
Car-t
7
Cardio
7
Cel
7
Chmp
14
Clinical-trials-phase-ii
14
Clinical-trials-phase-iii
10
Collaboration
23
Conference
12
Covid-19
5
Disease
18
Drug
51
Earnings
16
Europe
15
Ev
6
Events
18
Expected
7
Fda
9
Financial results
17
Food
19
For
35
Global
20
Growing
11
Growth
20
Immunotherapy
14
Int230
9
Iot
11
License
9
Market
56
N/a
217
Opdivo
17
People
11
Pharm-country
38
Pharmaceutical
9
Phase 1
9
Phase 2
9
Phase 3
12
Positive
22
Product-news
14
Psoriasis
6
Regulatory
6
Renal
8
Report
31
Research
47
Results
46
Solid tumors
10
T-cell
8
Therapeutics
27
Therapy
53
Treatment
62
Trial
32
Entities
Abbott laboratories
20
Abbvie inc.
52
Abeona therapeutics inc.
4
Adc therapeutics sa
13
Agenus inc.
5
Agios pharmaceuticals, inc.
12
Albemarle corporation
5
Alexion pharmaceuticals, inc.
15
Alnylam pharmaceuticals, inc.
10
Amgen inc.
62
Astellas pharma inc
4
Astrazeneca plc
36
Aveo pharmaceuticals, inc.
18
Ayala pharmaceuticals, inc.
4
Bausch health companies inc.
5
Beigene, ltd.
10
Biocryst pharmaceuticals, inc.
13
Biogen inc.
4
Biohaven pharmaceutical holding company ltd.
4
Biomarin pharmaceutical inc.
5
Bluebird bio, inc.
5
Blueprint medicines corporation
19
Bolt biotherapeutics inc
6
Bristol-myers squibb company
443
Clovis oncology, inc.
20
Compugen ltd.
4
Eli lilly and company
79
Epizyme, inc.
18
Exelixis, inc.
26
Genmab a/s
4
Gilead sciences, inc.
34
Glaxosmithkline plc
50
Gritstone oncology, inc.
4
Illumina, inc.
10
Incyte corporation
20
Intensity therapeutics, inc.
12
Johnson & johnson
54
Karyopharm therapeutics inc.
18
Medtronic plc
6
Mylan n.v.
11
Nektar therapeutics
7
Neos therapeutics, inc.
13
Novartis ag
64
Novo nordisk a/s
4
Omeros corporation
13
Otonomy, inc.
13
Pfizer, inc.
52
Regeneron pharmaceuticals, inc.
28
Replimune group, inc.
6
Rigel pharmaceuticals, inc.
11
Sanofi
88
Takeda pharmaceutical company limited
30
Teva pharmaceutical industries limited
4
Teva pharmaceutical industries ltd
19
Turning point therapeutics, inc.
6
Ucb s.a.
4
Verastem, inc.
11
Viatris inc.
8
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
18
Symbols
AAPL
687
ABB
870
ABBV
636
ABLZF
611
ABT
1020
AMGN
476
ARVL
2407
AZN
407
BDX
555
BMY
444
BNPQF
971
BNPQY
971
BNPZY
970
BSX
398
CNY
969
CSCO
598
DHR
483
ERIC
1022
EXTR
478
FNCTF
3460
FRBA
397
GE
646
GLAXF
398
GOOG
513
GOOGL
513
GSK
597
HON
1073
HUBS
1010
IBM
418
INR
972
INTC
617
JNJ
2875
LLY
1127
LTUM
528
LYV
459
MDT
868
MLPY
970
MMM
634
MS
2595
MS-PE
398
MSFT
835
NOK
477
NOKBF
460
NVO
398
NVS
728
NVSEF
525
ORCL
774
PFE
502
PHG
613
PPRUF
593
PPRUY
594
SAP
942
SAPGF
677
SNOW
517
SNY
2651
SNYNF
1706
TMO
929
TOT
995
URR
968
VZ
639
Exchanges
Amex
2
Lse
23
Nasdaq
262
Nyse
443
Tsx
4
Crawled Date
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 08 - 03
2
2021 - 07 - 30
3
2021 - 07 - 27
3
2021 - 07 - 16
2
2021 - 07 - 09
3
2021 - 07 - 08
2
2021 - 07 - 01
2
2021 - 06 - 29
2
2021 - 06 - 25
3
2021 - 06 - 24
2
2021 - 06 - 18
2
2021 - 06 - 17
2
2021 - 06 - 11
2
2021 - 06 - 10
5
2021 - 06 - 09
2
2021 - 06 - 04
3
2021 - 06 - 02
2
2021 - 05 - 25
4
2021 - 05 - 21
2
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
4
2021 - 04 - 07
3
2021 - 03 - 29
2
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 16
2
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Crawled Time
00:00
10
00:01
1
01:00
4
02:00
2
03:00
2
04:00
1
05:00
1
06:00
1
07:00
2
08:00
3
08:20
1
09:00
2
10:00
5
10:41
1
10:43
1
10:51
2
10:57
1
11:00
16
11:36
1
12:00
84
12:02
1
12:04
1
12:15
15
12:20
10
12:24
1
12:30
8
12:34
1
13:00
45
13:07
1
13:13
1
13:15
4
13:17
1
13:20
8
13:27
1
13:30
3
13:50
1
14:00
22
14:03
1
14:15
1
14:20
6
14:30
5
14:58
1
15:00
23
15:01
1
15:15
2
15:20
3
15:49
1
16:00
20
16:01
1
16:20
1
17:00
18
18:00
12
18:04
2
18:26
2
18:31
2
19:00
11
20:00
12
21:00
20
22:00
12
23:00
6
Source
feed.businesswire.com
2
savarapharma.com
1
www.biospace.com
226
www.fda.gov
45
www.globenewswire.com
29
www.prnewswire.com
141
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Bmy
save search
Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published:
2023-01-27
(Crawled : 13:20)
- prnewswire.com
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-0.5%
|
O:
-0.5%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
0.06%
|
O:
0.06%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
-0.27%
|
O:
-0.27%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-0.18%
|
O:
-0.18%
H:
0.0%
C:
0.0%
research
global
antiviral
market
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Published:
2023-01-27
(Crawled : 13:00)
- biospace.com/
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
-0.27%
|
O:
-0.27%
H:
0.0%
C:
0.0%
reblozyl
for
chmp
positive
Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis
Published:
2023-01-27
(Crawled : 13:00)
- biospace.com/
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
-0.27%
|
O:
-0.27%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-0.57%
|
O:
-0.57%
H:
0.0%
C:
0.0%
treatment
for
chmp
psoriasis
positive
Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
Published:
2023-01-26
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
4 d
|
$90.0
0
|
Health Technology
|
-1.1%
|
O:
-1.1%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-3.0%
|
O:
-1.25%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.42%
|
O:
0.7%
H:
0.0%
C:
0.0%
REGN
|
News
|
$742.84
0.07%
0.07%
410K
|
Health Technology
|
1.96%
|
O:
1.46%
H:
0.0%
C:
0.0%
global
report
roche
market
Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Published:
2023-01-26
(Crawled : 13:20)
- biospace.com/
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.42%
|
O:
0.7%
H:
0.0%
C:
0.0%
breyanzi
leukemia
trial
response
transcend
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
TAK
|
News
|
$16.03
-0.43%
0.0%
3.7M
|
Health Technology
|
-0.68%
|
O:
0.03%
H:
0.0%
C:
0.0%
NVO
|
$138.09
0.4%
1.38%
1.1M
|
Health Technology
|
-1.59%
|
O:
0.14%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.98%
|
O:
0.0%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-1.86%
|
O:
-1.45%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
0.37%
|
O:
0.23%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.14%
|
O:
-1.35%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.05%
|
O:
0.19%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-3.18%
|
O:
-2.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.51%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
F
|
$83.7
0.1%
0.1%
4.1M
|
Health Technology
|
-0.14%
|
O:
0.43%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-3.58%
|
O:
-0.9%
H:
0.0%
C:
0.0%
global
report
growth
market
Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published:
2023-01-18
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.98%
|
O:
0.0%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-1.86%
|
O:
-1.45%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.05%
|
O:
0.19%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.51%
|
O:
-0.92%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-3.58%
|
O:
-0.9%
H:
0.0%
C:
0.0%
research
report
growth
market
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
PFE
|
$43.79
-1.04%
0.0%
23M
|
Health Technology
|
-7.56%
|
O:
-2.74%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-2.81%
|
O:
0.51%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.65%
|
O:
1.94%
H:
0.52%
C:
-1.09%
ABT
|
News
|
$109.95
-1.01%
0.0%
4.9M
|
Health Technology
|
-0.56%
|
O:
2.05%
H:
0.69%
C:
-0.1%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-1.56%
|
O:
1.1%
H:
0.22%
C:
0.02%
GILD
F
|
$83.7
0.1%
0.1%
4.1M
|
Health Technology
|
-2.14%
|
O:
0.7%
H:
0.37%
C:
-0.74%
hepatitis
global
antiviral
hiv
therapeutics
growth
market
Charles LaPree
Published:
2023-01-12
(Crawled : 21:00)
- savarapharma.com
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-3.99%
|
O:
-0.83%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.33%
|
O:
-0.36%
H:
0.37%
C:
-0.11%
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
Published:
2023-01-11
(Crawled : 14:00)
- biospace.com/
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-3.98%
|
O:
0.01%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
2.27%
|
O:
0.32%
H:
0.66%
C:
0.6%
WBA
|
$37.17
1.84%
1.8%
5.9M
|
Retail Trade
|
0.34%
|
O:
2.27%
H:
0.24%
C:
-0.22%
GERN
|
$3.35
-0.59%
-0.6%
3.6M
|
Health Technology
|
15.02%
|
O:
11.95%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-6.26%
|
O:
1.54%
H:
0.0%
C:
0.0%
for
commercial
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published:
2023-01-09
(Crawled : 16:00)
- prnewswire.com
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-1.9%
|
O:
1.97%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.85%
|
O:
1.12%
H:
0.27%
C:
-3.89%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.76%
|
O:
1.06%
H:
0.05%
C:
-2.89%
BNTX
|
$143.69
0.81%
0.8%
440K
|
Health Technology
|
-3.38%
|
O:
2.93%
H:
0.0%
C:
0.0%
research
car-t
therapy
market
Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors
Published:
2023-01-06
(Crawled : 14:20)
- prnewswire.com
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-1.82%
|
O:
0.08%
H:
0.0%
C:
0.0%
GE
|
$83.23
2.58%
-0.08%
7.8M
|
Electronic Technology
|
15.91%
|
O:
3.1%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.46%
|
O:
0.7%
H:
0.0%
C:
0.0%
BPMC
|
$47.79
0.08%
0.08%
280K
|
Health Technology
|
0.32%
|
O:
-1.78%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-3.22%
|
O:
2.43%
H:
0.0%
C:
0.0%
Hestia Insight Inc. Appoints Advisory Board Member to Assist in Company Growth
Published:
2023-01-05
(Crawled : 12:20)
- globenewswire.com
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.66%
|
O:
-0.79%
H:
0.0%
C:
0.0%
growth
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published:
2023-01-04
(Crawled : 21:00)
- prnewswire.com
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
-0.67%
|
O:
-2.81%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-4.8%
|
O:
-0.69%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.66%
|
O:
-0.79%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$146.28
-0.76%
0.06%
4.6M
|
Health Technology
|
-10.05%
|
O:
-0.39%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-1.5%
|
O:
-3.07%
H:
0.0%
C:
0.0%
global
active
report
teva
market
Bristol Myers Squibb to Present at J.P. Morgan’s 41st Annual Healthcare Conference
Published:
2023-01-03
(Crawled : 14:00)
- biospace.com/
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.98%
|
O:
-0.58%
H:
0.0%
C:
0.0%
conference
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York
Published:
2023-01-03
(Crawled : 14:00)
- biospace.com/
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.98%
|
O:
-0.58%
H:
0.0%
C:
0.0%
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
PFE
|
$43.79
-1.04%
0.0%
23M
|
Health Technology
|
-13.95%
|
O:
0.02%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.39%
|
O:
-0.03%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-5.05%
|
O:
-0.01%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.11%
|
O:
0.13%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-0.08%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
F
|
$83.7
0.1%
0.1%
4.1M
|
Health Technology
|
-1.92%
|
O:
-0.12%
H:
0.0%
C:
0.0%
EXEL
M
|
$17.48
-1.3%
-1.32%
1.6M
|
Health Technology
|
13.09%
|
O:
0.03%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-3.1%
|
O:
-0.5%
H:
0.0%
C:
0.0%
global
disease
report
therapeutics
cancer
market
Hagens Berman Sobol Shapiro LLP, Hilliard & Shadowen LLP, and Durie Tangri LLP Announce a Class Action Involving Antiretroviral Drugs
Published:
2022-12-28
(Crawled : 21:00)
- prnewswire.com
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-5.29%
|
O:
-0.26%
H:
0.42%
C:
0.01%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
0.16%
|
O:
-0.66%
H:
0.47%
C:
-0.28%
GILD
F
|
$83.7
0.1%
0.1%
4.1M
|
Health Technology
|
-2.29%
|
O:
-0.78%
H:
0.78%
C:
0.41%
Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb
Published:
2022-12-16
(Crawled : 12:00)
- biospace.com/
EVO
|
$10.34
1.55%
9.7K
|
Manufacturing
|
24.73%
|
O:
-1.69%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
-5.14%
|
O:
-3.19%
H:
0.0%
C:
0.0%
collaboration
Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023
Published:
2022-12-15
(Crawled : 13:00)
- biospace.com/
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
-6.39%
|
O:
-1.32%
H:
0.0%
C:
0.0%
report
for
results
← Previous
1
2
3
4
5
6
7
8
9
…
22
23
Next →
Gainers vs Losers
66%
34%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.